Biotech · Private company
Woolsey Pharmaceuticals
Track this companyFree. Adds Woolsey Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- FasudilPhase 2 · Progressive Supranuclear PalsyClinicalTrials.gov · fetched Nov 12, 2026
- Fasudil (WP-0512)Phase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Oral Fasudil 180 mg/dayPhase 2 · DementiaClinicalTrials.gov · fetched Nov 12, 2026
- Oral Fasudil 90 mg/dayPhase 2 · DementiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 22, 2021ClinicalTrials.gov NCT05218668 · fetched Nov 12, 2026
- Rho Kinase (ROCK) Inhibitor in Tauopathies - 1PHASE2 · UNKNOWN · started Jan 22, 2021ClinicalTrials.gov NCT04734379 · fetched Nov 12, 2026
- Fasudil fOr redUcing elopemeNt and Spatial DisorientationPHASE2 · COMPLETED · started Dec 15, 2020ClinicalTrials.gov NCT04793659 · fetched Nov 12, 2026